|1.||Kohno, Shigeru: 4 articles (07/2013 - 01/2002)|
|2.||Kuti, Joseph L: 4 articles (02/2008 - 01/2005)|
|3.||Nicolau, David P: 4 articles (02/2008 - 01/2005)|
|4.||Dartois, Nathalie: 3 articles (04/2013 - 09/2005)|
|5.||Babinchak, Timothy: 3 articles (01/2010 - 01/2005)|
|6.||Cooper, Angel: 3 articles (01/2010 - 09/2006)|
|7.||Wu, Shu-Chen: 3 articles (05/2006 - 02/2003)|
|8.||Susic, Veselinka: 3 articles (04/2004 - 02/2004)|
|9.||Zivanovic, Dragana: 3 articles (04/2004 - 02/2004)|
|10.||Okuno, Yuji: 2 articles (04/2015 - 06/2013)|
02/01/1988 - "Imipenem/cilastatin is highly effective for infections in many body sites against a broad range of gram-positive and gram-negative aerobic and anaerobic bacteria. "
06/07/1985 - "Preliminary data indicate that imipenem/cilastatin is very effective in the therapy of this serious infection; however its place in the therapeutic armamentarium awaits the completion of randomized prospective studies against established drugs."
12/01/1986 - "In this study imipenem/cilastatin was used successfully to treat 21 patients with a variety of severe infections caused by Gram-positive and Gram-negative aerobic bacteria. "
01/01/1991 - "The efficacy and low incidence of side effects of the intramuscular formulation of imipenem/cilastatin are significant advantages in the cost-effective treatment of infections."
01/01/1988 - "Imipenem-cilastatin appears to be an effective antibiotic in treating polymicrobial infections; however, a much larger patient population would be required to detect a significant difference in the efficacy rates or frequency of adverse effects when comparing the two regimens."
06/01/2014 - "Imipenem/cilastatin therapy was found to be effective for the treatment of Legionella pneumonia in this patient."
02/01/1985 - "Results of this study suggest that primaxin will be useful in the treatment of a variety of serious Gram-positive and Gram-negative pneumonias. "
06/01/2006 - "The efficacy and safety of P/T was compared with imipenem/cilastatin (I/C) in patients with established nosocomial pneumonia. "
12/01/2004 - "One week later, the patient developed pneumonia, and imipenem/cilastatin was added. "
04/01/2003 - "Rapid imipenem/cilastatin desensitization for multidrug-resistant Acinetobacter pneumonia."
|3.||Urinary Tract Infections (Urinary Tract Infection)
06/07/1985 - "Safety and efficacy of imipenem/cilastatin in treatment of complicated urinary tract infections."
01/01/2015 - "Another phase II clinical trial has demonstrated that clinical cure rates with CAZ/AVI are comparable to those with imipenem/cilastatin for the treatment of adults with complicated urinary tract infections (cUTIs). "
01/01/1992 - "To determine the cost relative to efficacy and tolerability of two antimicrobial regimens, a prospective, multicenter study compared imipenem-cilastatin (I-C) monotherapy with clindamycin+aminoglycoside (C+A) in the treatment of serious lower respiratory, intra-abdominal, gynecologic, and urinary tract infections. "
01/01/1992 - "Cost-analysis of imipenem-cilastatin monotherapy compared with clindamycin+aminoglycoside combination therapy for treatment of serious lower respiratory, intra-abdominal, gynecologic, and urinary tract infections."
01/01/1986 - "A total of 20 urological patients suffering from complicated urinary tract infections (15 men, five women) received a short-term i.v. infusion of 0.5 mg imipenem/cilastatin t.i.d. "
10/01/2000 - "After sepsis treatment with imipenem-cilastatin and aminoglycoside, remission of hemophagocytosis was achieved."
01/01/1987 - "The clinical efficacy and safety of imipenem/cilastatin in the empirical treatment of adult non-immunocompromised patients with severe bacterial septicemia was studied in a prospective and open trial. "
01/01/1995 - "The effects of experimental splenic autotransplantation and imipenem-cilastatin treatment in postsplenectomy Pseudomonas aeruginosa sepsis."
05/31/1989 - "[Monotherapy, empirical and targetted, with imipenem-cilastatin in sepsis of bacterial origin]."
07/25/1988 - "One patient in the imipenem/cilastatin arm died of Pseudomonas aeruginosa sepsis. "
|5.||Respiratory Tract Infections (Respiratory Tract Infection)
06/07/1985 - "Monotherapy with imipenem/cilastatin of serious lower respiratory tract infections was relatively safe and highly effective with the exception of disease associated with P. "
01/01/1988 - "Imipenem-cilastatin in the treatment of respiratory infections in patients with chronic airways obstruction."
12/01/1986 - "Six patients, aged between 68 and 83 years, with glomerular filtration rates (GFR) between 31 and 80 ml/min received imipenem/cilastatin as treatment for acute lower respiratory tract infection. "
07/01/1985 - "Imipenem/cilastatin compares well with the most active agents available for therapy for lower respiratory tract infections."
07/01/1985 - "Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience."
|1.||Drug Therapy (Chemotherapy)
|2.||Continuous Ambulatory Peritoneal Dialysis (CAPD)
|3.||Combination Drug Therapy (Combination Chemotherapy)
|4.||Stem Cell Transplantation
|5.||Renal Dialysis (Hemodialysis)